Genetic Testing for Mental Health Approved as New Ally for Military Personnel and Veterans
Veterans and active military personnel are now eligible to receive the Genecept Assay®, a genetic test for mental health that helps patients feel better.
Clinicians and Patients Gain Powerful Advanced Test for Mental Health as the Genecept Assay Builds on Existing Patient Success
Genomind has expanded its existing panel to 18 total genes based on the critical examination of hundreds of published studies showing that variations in these genes can inform treatment decisions in p
Genomind’s Cutting-Edge Pharmacogenetic Testing To Be Featured On Educational “Innovations” TV Series
“Innovations,” an award-winning television series seen on the Discovery Channel, will feature Genomind in a seven-minute segment that is set to premiere Monday, Dec. 14 at 7:30 a.m. EST and 7:30 a.m.
Genomind Appoints New Chief Medical Officer as Personalized Medicine Company Advances Work on Brain Health
Genomind Appoints New Chief Medical Officer as Personalized Medicine Company Advances Work on Brain Health
Personalized Medicine for Mental Health Revolutionizes Care as Advocates Mark Mental Illness Awareness Week and World Mental Health Day
Personalized Medicine for Mental Health Revolutionizes Care as Advocates Mark Mental Illness Awareness Week and World Mental Health Day
Genomind Secures Latest Round of Financing that Will Solidify Strategic Plan for Company’s Growth
Genomind Secures Latest Round of Financing that Will Solidify Strategic Plan for Company’s Growth
Genomind is excited to appoint Rina Wolf to its Board of Directors
Genomind is excited to appoint Rina Wolf to its Board of Directors
Genecept Assay Open Label Trial Results Published In The Primary Care Companion For CNS Disorders
Genecept Assay Open Label Trial Results Published In The Primary Care Companion For CNS Disorders
Genomind Expands And Strengthens Leadership Team
Genomind Expands And Strengthens Leadership Team
New Evidence Shows Genetic Testing May Help Target Use of Antidepressants
New Evidence Shows Genetic Testing May Help Target Use of Antidepressants
Genomind Case Studies Published In Primary Care Companion For CNS Disorders
Genomind Case Studies Published In Primary Care Companion For CNS Disorders
Genomind White Paper Describing The Clinical Utility Of Pharmacogenetic Testing In Psychiatry Published In Psychiatry Journal
Genomind White Paper Describing The Clinical Utility Of Pharmacogenetic Testing In Psychiatry Published In Psychiatry Journal
Genomind To Exhibit At 2014 NEI Psychopharmacology Congress
Genomind To Exhibit At 2014 NEI Psychopharmacology Congress
Genomind To Attend The American Academy Of Child & Adolescent Psychiatry (AACAP) Annual Meeting
Genomind To Attend The American Academy Of Child & Adolescent Psychiatry (AACAP) Annual Meeting
Genomind Welcomes New Executive Team Member Thomas Hess
Genomind Welcomes New Executive Team Member Thomas Hess
Genomind Clinical Study Demonstrates effectiveness of the Genecept™ Assay
Genomind Clinical Study Demonstrates effectiveness of the Genecept™ Assay
Genomind To Exhibit At The APA Annual Meeting And The Clinical TMS Society Meeting
Genomind To Exhibit At The APA Annual Meeting And The Clinical TMS Society Meeting
Genomind Secures Series A Investment Led By Claritas Capital To Fund Growth Of Their Personalized Medicine Company
Genomind Secures Series A Investment Led By Claritas Capital To Fund Growth Of Their Personalized Medicine Company
ValueOptions And Genomind Announce Innovative Study Of Pharmacogenomic Testing For Treating Psychotic Disorders
ValueOptions And Genomind Announce Innovative Study Of Pharmacogenomic Testing For Treating Psychotic Disorders
Genomind Announces New Patient Outcomes Data Supporting Use Of The Genecept Assay
Genomind Announces New Patient Outcomes Data Supporting Use Of The Genecept Assay
Genomind’s Genetic Testing At Princeton House Promotes Personalized Care
Genomind’s Genetic Testing At Princeton House Promotes Personalized Care
Genomind To Exhibit At The American Academy Of Anti-Aging (A4M) Congress
Genomind To Exhibit At The American Academy Of Anti-Aging (A4M) Congress
Genomind Announces New Patient Outcomes Data Supporting Use Of The Genecept Assay At NEI Global Psychopharmacology Congress
Genomind Announces New Patient Outcomes Data Supporting Use Of The Genecept Assay At NEI Global Psychopharmacology Congress
Dr. Jay Lombard Of Genomind Selected To Speak At Partnering For Cures (P4C) On “Mental Health: Research And Development At A Crossroads”
Dr. Jay Lombard Of Genomind Selected To Speak At Partnering For Cures (P4C) On “Mental Health: Research And Development At A Crossroads”
Genomind Announces Licensing Agreement With Emory University To Commercialize Novel Alzheimer’s Risk Biomarkers
Genomind Announces Licensing Agreement With Emory University To Commercialize Novel Alzheimer’s Risk Biomarkers
Genomind To Attend and Exhibit At The AACAP Meeting
Genomind To Attend and Exhibit At The AACAP Meeting
Genomind To Participate In APNA Annual Conference
Genomind To Participate In APNA Annual Conference
Genomind Presents New Data Supporting Use Of The Genecept™ Assay At ISCTM
Genomind Presents New Data Supporting Use Of The Genecept™ Assay At ISCTM
Genomind Launches New Clinician Portal
Genomind Launches New Clinician Portal
Genomind Demonstrates Broader Commitment To The Mental Health Community
Genomind Demonstrates Broader Commitment To The Mental Health Community